Literature DB >> 12014847

Vitamin D deficiency and aging: implications for general health and osteoporosis.

Erik Fink Eriksen1, Henning Glerup.   

Abstract

Vitamin D deficiency is extremely prevalent in the elderly. Most often the first symptoms are caused by myopathy with muscle pain, fatigue, muscular weakness and gait disturbances. More severe deficiency causes osteomalacia with deep bone pain, reduced mineralization of bone matrix and low energy fractures. Recent data also suggest that hypovitaminosis D increases the risk of cancer of the prostate, colon and breast. Thus, hypovitaminosis D is associated with many diseases associated with aging. In order to diagnose hypovitaminosis D, the assessment of serum levels of 25-hydroxy vitamin D is mandatory. Screening based on other markers like alkaline phosphatase and parathyroid hormone (PTH) will be incomplete. The treatment of hypovitaminosis D is simple with administration of combined calcium (I g) and vitamin D supplements (calciferol, at least 800 IU). Severe cases may demand initial parenteral administration of vitamin D (repeated injections of 300,000 IU 2-3 times with monthly intervals). More potent analogues are rarely needed. One should aim at achieving S-25(OH)D values in the range 50-100 nmol/l.

Entities:  

Mesh:

Year:  2002        PMID: 12014847     DOI: 10.1023/a:1015263514765

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  15 in total

Review 1.  Resurgence of vitamin D: Old wine in new bottle.

Authors:  Raju Vaishya; Vipul Vijay; Amit Kumar Agarwal; Jabed Jahangir
Journal:  J Clin Orthop Trauma       Date:  2015-03-26

2.  An investigation of the levels of vitamins A, D, and E in the serum of Chinese pregnant women.

Authors:  Yu-Juan Chen; Zhan-Dong Li; Cui-Ying Mao; Xu Kang; Shu-Hua Zhang
Journal:  J Clin Lab Anal       Date:  2017-02-21       Impact factor: 2.352

3.  Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study.

Authors:  Cassianne Robinson-Cohen; Ronit Katz; Andrew N Hoofnagle; Jane A Cauley; Curt D Furberg; John A Robbins; Zhao Chen; David S Siscovick; Ian H de Boer; Bryan Kestenbaum
Journal:  J Clin Endocrinol Metab       Date:  2011-04-20       Impact factor: 5.958

4.  Age-dependent responsiveness of human female bone cells to vitamin D analog and PTH.

Authors:  D Somjen; S Katzburg; A M Kaye; G H Posner
Journal:  J Endocrinol Invest       Date:  2013-02       Impact factor: 4.256

5.  Prevalence of vitamin D deficiency in patients attending an outpatient cancer care clinic in Boston.

Authors:  Vin Tangpricha; Natalia A Colon; Heema Kaul; Shirley L Wang; Sheila Decastro; Rita A Blanchard; Tai C Chen; Michael F Holick
Journal:  Endocr Pract       Date:  2004 May-Jun       Impact factor: 3.443

6.  Shelf life after opening of prescription medicines and supplements with vitamin D3 for paediatric use.

Authors:  Žane Temova; Robert Roškar
Journal:  Eur J Hosp Pharm       Date:  2016-05-06

7.  Asymptomatic severe hypocalcemia secondary to vitamin d deficiency in an elderly patient.

Authors:  Saleh Aldasouqi; Crystal M Glassy; Matthew S Glassy; Anxhela Treska; Molly Caldwell-McMillan; Ved Gossain
Journal:  Case Rep Endocrinol       Date:  2011-11-02

8.  Biochemical recovery time scales in elderly patients with osteomalacia.

Authors:  S C Allen; S Raut
Journal:  J R Soc Med       Date:  2004-11       Impact factor: 18.000

9.  Age-related changes in the epithelial and stromal compartments of the mammary gland in normocalcemic mice lacking the vitamin D3 receptor.

Authors:  JoEllen Welsh; Lindsay N Zinser; Laurel Mianecki-Morton; Jamie Martin; Susan E Waltz; Howard James; Glendon M Zinser
Journal:  PLoS One       Date:  2011-01-26       Impact factor: 3.240

Review 10.  Prevalence of vitamin D deficiency among Turkish, Moroccan, Indian and sub-Sahara African populations in Europe and their countries of origin: an overview.

Authors:  I M van der Meer; B J C Middelkoop; A J P Boeke; P Lips
Journal:  Osteoporos Int       Date:  2010-05-12       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.